Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11312437.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Skin and nail changes from long-term hydroxyurea therapy are reported in adults. Skin and nail changes, including nail hyperpigmentation, longitudinal bands, and hyperpigmentation of the palms and other skin surfaces, developed in 7 children with sickle cell anemia after 6 to 16 weeks of hydroxyurea therapy. Cutaneous and nail changes may occur in children receiving hydroxyurea.
Medical subject headings
- Anemia, Sickle Cell
- Antisickling Agents
- Hydroxyurea
- Hyperpigmentation
- Nail Diseases
- Skin Diseases